Comparative analysis between the two groups indicated that patients in the prostate cancer group had higher age, SII, uric acid, and PSA levels compared to the BPH group, whereas BMI, lymphocyte count, hemoglobin, and PDW were lower in the prostate cancer group. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.